Skip to main content

Beta Bionics, Inc. insider trading

BBNXNASDAQ
$18.96+0.09 (+0.48%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-7.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • WHWellington Hadley Harbor Aggregator IV, L.P.10% Owner8.6722%of company
  • SSSean SaintPresident & CEO0.8856%of company
  • MMMike MensingerChief Product Officer0.3943%of company
  • SJSteven Jon RussellChief Medical Officer0.377%of company
  • SFStephen FeiderChief Financial Officer0.3543%of company
  • MHMark HopmanChief Commercial Officer0.1957%of company
  • ALAdam LezackDirector0.124%of company
  • GJGerard J. MichelDirector0.0745%of company
  • SCSean CarneyDirector0.0716%of company
  • DLDanny L. DearenDirector0.0716%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
BBNXChristy JonesDirectorOpen market sell$148K-24.7%$23.00$148KSep 22, 2026Sep 23, 2026
BBNXMike MensingerChief Product OfficerOpen market sell$58.3K-1.5%$22.00$58.3KSep 16, 2026Sep 17, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$620K-35.3%$20.13$620KSep 16, 2026Sep 17, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$12K-0.9%$15.52$12KSep 14, 2026Sep 15, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$665K-29.0%$18.46$665KSep 9, 2026Sep 18, 2026
BBNXSean SaintPresident & CEOOpen market sell$113K-1.4%$20.08$113KSep 3, 2026Sep 4, 2026
BBNXSteven Jon RussellChief Medical OfficerOpen market sell$80.7K-2.4%$19.11$80.7KSep 2, 2026Sep 3, 2026
BBNXSean SaintPresident & CEOOpen market sell$322K-4.0%$19.11$322KSep 2, 2026Sep 3, 2026
BBNXStephen FeiderChief Financial OfficerOpen market sell$128K-4.0%$19.11$128KSep 2, 2026Sep 3, 2026
BBNXMike MensingerChief Product OfficerOpen market sell$83.6K-2.4%$19.11$83.6KSep 2, 2026Sep 3, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$102K-4.1%$19.11$102KSep 2, 2026Sep 3, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$18.9K-1.0%$15.01$18.9KJun 24, 2026Jun 25, 2026
BBNXChristy JonesDirectorOpen market sell$21.1K-5.1%$15.00$21.1KJun 24, 2026Jun 25, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$3.39K-0.2%$12.31$3.39KJun 4, 2026Jun 5, 2026
BBNXChristy JonesDirectorOpen market sell$39.4K-9.3%$14.00$39.4KJun 4, 2026Jun 5, 2026
BBNXSteven Jon RussellChief Medical OfficerOpen market sell$53.2K-2.4%$12.61$53.2KJun 2, 2026Jun 3, 2026
BBNXSean SaintPresident & CEOOpen market sell$213K-3.9%$12.61$213KJun 2, 2026Jun 3, 2026
BBNXStephen FeiderChief Financial OfficerOpen market sell$84.2K-3.9%$12.61$84.2KJun 2, 2026Jun 3, 2026
BBNXMike MensingerChief Product OfficerOpen market sell$55.2K-2.3%$12.61$55.2KJun 2, 2026Jun 3, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$67.2K-3.9%$12.61$67.2KJun 2, 2026Jun 3, 2026
BBNXAdam LezackDirectorOpen market sell$11.2K-1.8%$11.21$11.2KMay 22, 2026May 26, 2026
BBNXChristy JonesDirectorOpen market sell$19.9K-13.1%$9.95$19.9KMay 21, 2026May 26, 2026
BBNXAdam LezackDirectorOpen market sell$9.95K-2.5%$9.95$9.95KMay 21, 2026May 26, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$4.08K-0.3%$11.57$4.08KMar 4, 2026Mar 5, 2026
BBNXMike MensingerChief Product OfficerOpen market sell$66.2K-2.7%$30.10$66.2KJan 6, 2026Jan 7, 2026
BBNXMike MensingerChief Product OfficerOpen market sell$18.1K-0.7%$30.20$18.1KJan 2, 2026Jan 5, 2026
BBNXMike MensingerChief Product OfficerOpen market sell$213K-7.9%$29.56$213KJan 2, 2026Jan 5, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$63.2K-1.5%$30.66$63.2KDec 4, 2025Mar 16, 2026
BBNXSteven Jon RussellChief Medical OfficerOpen market sell$30.1K-0.6%$29.34$30.1KDec 2, 2025Mar 16, 2026
BBNXMark HopmanChief Commercial OfficerOpen market sell$25.1K-0.6%$29.34$25.1KDec 2, 2025Mar 16, 2026
BBNXSean SaintPresident & CEOOpen market sell$96.2K-3.2%$29.34$96.2KDec 2, 2025Dec 4, 2025
BBNXStephen FeiderChief Financial OfficerOpen market sell$41.9K-3.2%$29.34$41.9KDec 2, 2025Dec 4, 2025
BBNXMike MensingerChief Product OfficerOpen market sell$31.2K-1.2%$29.34$31.2KDec 2, 2025Dec 4, 2025
BBNXAdam LezackDirectorOpen market sell$15K-5.6%$29.91$15KDec 1, 2025Dec 2, 2025
BBNXAdam LezackDirectorOpen market sell$26.6K-9.2%$29.35$26.6KDec 1, 2025Dec 2, 2025
BBNXMaria PalasisDirectorOpen market sell$15K-5.6%$29.96$15KDec 1, 2025Dec 2, 2025
BBNXMaria PalasisDirectorOpen market sell$26.6K-9.2%$29.33$26.6KDec 1, 2025Dec 2, 2025
BBNXAdam LezackDirectorOpen market sell$1.05K-0.4%$27.70$1.05KOct 31, 2025Nov 5, 2025
BBNXAdam LezackDirectorOpen market sell$36.7K-12.2%$26.85$36.7KOct 31, 2025Nov 5, 2025
BBNXMaria PalasisDirectorOpen market sell$3.27K-1.2%$27.45$3.27KOct 31, 2025Nov 5, 2025
BBNXMaria PalasisDirectorOpen market sell$34.6K-11.4%$26.86$34.6KOct 31, 2025Nov 5, 2025
End of history · 41 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.